Fuller & Thaler Asset Management
RPRX

Fuller & Thaler Asset Management’s Repros Therapeutics Inc. RPRX Stock Holding History

Fuller & Thaler Asset Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-168,800
Closed -$1.25M – 813
2015
Q3 		$1.25M Sell
168,800
-200
-0.1% -$1.53K 0.03% 235
2015
Q2 		$1.21M Buy
169,000
+3,600
+2% +$28K 0.03% 253
2015
Q1 		$1.42M Hold
165,400
– – 0.05% 243
2014
Q4 		$1.65M Buy
+165,400
New +$1.41M 0.06% 222

Other funds holding RPRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
AIA
Allegis Investment Advisors Idaho Falls, Idaho $326M AUM 10.36% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Fuller & Thaler Asset Management's RPRX Position: Q4 2015 in Review

Fuller & Thaler Asset Management sold out of Repros Therapeutics Inc. (RPRX) in Q4 2015, closing a stake of 168,800 shares — an estimated $1.25M sold.

Fuller & Thaler Asset Management first reported a position in RPRX in Q4 2014 and held it in 4 quarters. The position peaked at $1.65M in Q4 2014. 56 funds tracked by Wall St. Rank hold RPRX as of Q4 2015.

  • Fuller & Thaler Asset Management reported no remaining Repros Therapeutics Inc. position as of Q4 2015 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 168,800 Repros Therapeutics Inc. shares in Q4 2015, an estimated $1.25M.
  • Fuller & Thaler Asset Management first reported a position in Repros Therapeutics Inc. in Q4 2014 and held it in 4 quarters.
  • Fuller & Thaler Asset Management's Repros Therapeutics Inc. position peaked at $1.65M in Q4 2014.
  • 56 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q4 2015.

Based on Fuller & Thaler Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.